262 related articles for article (PubMed ID: 3428717)
1. Effect of heparin, hirudin, and a synthetic thrombin inhibitor on antithrombin III in thrombin-induced disseminated intravascular coagulation in rats.
Hauptmann J; Brüggener E; Markwardt F
Haemostasis; 1987; 17(6):321-8. PubMed ID: 3428717
[TBL] [Abstract][Full Text] [Related]
2. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
Hauptmann J; Brüggener E
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
[TBL] [Abstract][Full Text] [Related]
3. Effect of a synthetic thrombin inhibitor MCI-9038 on experimental models of disseminated intravascular coagulation in rabbits.
Hara H; Tamao Y; Kikumoto R; Okamoto S
Thromb Haemost; 1987 Apr; 57(2):165-70. PubMed ID: 3603410
[TBL] [Abstract][Full Text] [Related]
4. [Effects of low molecular weight heparin (FR-860) on the experimental disseminated intravascular coagulation models].
Hamano S; Kinukawa M; Komatsu H; Miyata H; Sakuragawa N
Nihon Yakurigaku Zasshi; 1991 Jul; 98(1):53-62. PubMed ID: 1889762
[TBL] [Abstract][Full Text] [Related]
5. The effect of hirudin on endotoxin induced disseminated intravascular coagulation (DIC).
Ishikawa A; Hafter R; Seemüller U; Gokel JM; Graeff H
Thromb Res; 1980 Aug; 19(3):351-8. PubMed ID: 7434319
[No Abstract] [Full Text] [Related]
6. Formation of fibrin monomers in experimental disseminated intravascular coagulation and its inhibition by recombinant hirudin.
Dickneite G; Czech J; Keuper H
Circ Shock; 1994 Apr; 42(4):183-9. PubMed ID: 8055664
[TBL] [Abstract][Full Text] [Related]
7. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
[TBL] [Abstract][Full Text] [Related]
8. Hirudin in disseminated intravascular coagulation.
Nowak G; Markwardt F
Haemostasis; 1991; 21 Suppl 1():142-8. PubMed ID: 1894189
[TBL] [Abstract][Full Text] [Related]
9. Prednisolone inhibits endotoxin-induced disseminated intravascular coagulation and improves mortality in rats: importance of inflammatory cytokine suppression.
Yamazaki M; Aoshima K; Mizutani T; Ontachi Y; Saito M; Morishita E; Asakura H; Matsuda T; Triplett DA
Blood Coagul Fibrinolysis; 1999 Sep; 10(6):321-30. PubMed ID: 10493213
[TBL] [Abstract][Full Text] [Related]
10. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
[TBL] [Abstract][Full Text] [Related]
11. In vivo attempt to consume antithrombin III by i.v. injection of a thrombin-heparin mixture.
Soulier JP; Gozin D; Lerable J
Thromb Res; 1984 May; 34(3):255-62. PubMed ID: 6729779
[TBL] [Abstract][Full Text] [Related]
12. Effect of heparin on the interaction between thrombin and hirudin.
Stone SR; Hofsteenge J
Eur J Biochem; 1987 Dec; 169(2):373-6. PubMed ID: 3691497
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic and haemorrhagic effects of synthetic and naturally occurring thrombin inhibitors.
Kaiser B; Markwardt F
Thromb Res; 1986 Sep; 43(6):613-20. PubMed ID: 3764808
[TBL] [Abstract][Full Text] [Related]
14. Tissue thromboplastin induced reversible DIC and heparin-enhanced inhibitors in dogs.
Marbet GA; Griffith MJ
Thromb Haemost; 1986 Feb; 55(1):78-85. PubMed ID: 3518133
[TBL] [Abstract][Full Text] [Related]
15. Effects of low molecular weight heparin on a severely antithrombin III-decreased disseminated intravascular coagulation model in rabbits.
Tazawa S; Ichikawa K; Misawa K; Fukuyama J; Hamano S; Miyata H; Sakuragawa N
Thromb Res; 1995 Dec; 80(5):391-8. PubMed ID: 8588200
[TBL] [Abstract][Full Text] [Related]
16. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
Hérault JP; Bernat A; Gaich C; Herbert M
Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies on thrombin inhibitors in experimental microthrombosis.
Markwardt F; Nowak G; Hoffmann J
Thromb Haemost; 1983 Jun; 49(3):235-7. PubMed ID: 6603675
[TBL] [Abstract][Full Text] [Related]
18. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
Marbet GA; Griffith MJ; Roberts HR
Scand J Clin Lab Invest Suppl; 1985; 178():95-8. PubMed ID: 3867125
[TBL] [Abstract][Full Text] [Related]
19. Influence of thrombin inhibitors on the thrombin-induced activation of human blood platelets.
Markwardt F; Hoffmann A; Stürzebecher J
Haemostasis; 1983; 13(4):227-33. PubMed ID: 6618289
[TBL] [Abstract][Full Text] [Related]
20. A purified antithrombin III--heparin complex as a potent inhibitor of thrombin in porcine endotoxin shock.
Spannagl M; Hoffmann H; Siebeck M; Weipert J; Schwarz HP; Schramm W
Thromb Res; 1991 Jan; 61(1):1-10. PubMed ID: 2020936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
